Fingolimod modulates microglial activation to augment markers of remyelination

INTRODUCTION: Microglial activation in multiple sclerosis has been postulated to contribute to long-term neurodegeneration during disease. Fingolimod has been shown to impact on the relapsing remitting phase of disease by modulating autoreactive T-cell egress from lymph organs. In addition, it is br...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Samuel J, Giovannoni, Gavin, Baker, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152910/
https://www.ncbi.nlm.nih.gov/pubmed/21729281
http://dx.doi.org/10.1186/1742-2094-8-76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152910/
https://www.ncbi.nlm.nih.gov/pubmed/21729281
http://dx.doi.org/10.1186/1742-2094-8-76

Ejemplares similares